This can lead to various uncomfortable symptoms, such as nausea, vomiting, bloating, and a feeling of fullness
Mounjaro is primarily indicated for adults with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher accompanied by weight-related health conditions, such as hypertension or type 2 diabetes
[4] Whilst this increase is generally clinically insignificant, some patients may become more aware of their heartbeat, particularly if they are monitoring their health closely during weight loss treatment
Christensen M, Vedtofte L, Holst JJ, Vilsbll T, Knop FK (2011) Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans
Kim R, Nijhout HF, Reed MC
Can it truly accelerate recovery and improve overall well-being